SLU-PP-332 – The Exercise-Mimetic Peptide

SLU-PP-332 is studied for reproducing some of the metabolic signals of endurance exercise. An ERR agonist, and one of the newest compounds available. The published work is preclinical, which is exactly why it sits in the cutting-edge tier. 🧪 SLU-PP-332 — The Exercise-Mimetic Peptide Early, and honest about it. What it is, in plain English SLU-PP-332 activates estrogen-related receptors, the pathway muscle uses to shift toward fat oxidation and mitochondrial building during endurance training. It is among the least studied compounds on this shelf, and it is listed in the cutting-edge tier deliberately rather than presented as settled. How it helps 🏃 Studied for signals associated with endurance training ⚡ Acts on mitochondrial and fat-oxidation pathways 🧪 Among the newest compounds available 💧 Arrives pre-mixed — nothing to reconstitute Why people reach for it Some people want to be early. SLU-PP-332 is for those comfortable with a compound whose evidence base is still preclinical, and who would rather have that stated plainly than dressed up. MOTS-c SLU-PP-332 Research history Longer Very recent Human data Limited None published Target Mitochondrial ERR pathway Is it a fit? SLU-PP-332 suits someone comfortable being early to a compound and willing to discuss the evidence honestly first. Take the 60-second peptide quiz or message our team, and our providers can point the way. 🔬 For the science-minded SLU-PP-332 is a synthetic pan-ERR agonist developed at Saint Louis University. Rodent work has reported increased fatty-acid oxidation and running endurance without changes in food intake. Human data are not yet available, so any protocol reflects practical experience rather than clinical evidence. This compound has no published human dosing data. That distinction is worth understanding before starting. Educational only — not medical advice. Peptides discussed here are research compounds; whether any is appropriate is a decision between a patient and their licensed provider.